‘Strong Immune Response’ From One Dose of Pfizer Vaccine: Study

People previously infected with SARS-CoV-2 showed higher antibody and T-cell responses after one dose of Pfizer’s BNT162b2 messenger (mRNA) vaccine compared with people who had a first dose without previously contracting the virus, according to research led by the universities of Sheffield and Oxford. The early findings from the Protective […]

Read More